Richard Fisher steps down from leadership roles at Fox Chase Cancer Center

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions”

How’s this for a paradox: The better cancer centers become at keeping patients alive, the more expensive cancer care becomes. This brutal tradeoff hits harder in rural areas, where the cancer burden is higher and the investigator and clinical trial representation is lower.

June 26, 2026

Vol.52 No.25

By Paul Goldberg and Claire Marie Porter

In Brief

NCI renews the UC San Diego Moores CCSG, committing $25M

University of California San Diego Moores Cancer Center has received a five-year, $25 million Cancer Center Support Grant from NCI.

June 18, 2026

Vol.52 No.24

Capitol Hill

House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget

On June 9, the House Appropriations Committee passed its version of the fiscal year 2027 spending bill for Labor, Health and Human Services, and Education.

June 12, 2026

Vol.52 No.23

By Paul Goldberg

As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded

Last week, Wafik El-Deiry, a cancer researcher at Brown University, showed up at a Senate hearing to talk about what he sees as dangers of the COVID-19 vaccine.

NCI selects UChicago Medicine as a lead site for clinical trials

The University of Chicago Medicine Comprehensive Cancer Center has been granted a six-year, $5 million grant from NCI.

June 12, 2026

Vol.52 No.23

Podcast

As FDA’s wheels almost entirely come off, NCI remains sturdy—a cancer moonshot may even be on the horizon

While every agency under HHS, particularly FDA, has seen historic leadership shakeups and massive cuts to personnel and funding over the course of the second Trump administration—NCI has been spared, even getting a small raise, under the direction of NCI Director Anthony Letai.

May 27, 2026

Richard Fisher steps down from leadership roles at Fox Chase Cancer Center

YOU MAY BE INTERESTED IN

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions”

NCI renews the UC San Diego Moores CCSG, committing $25M

House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget

As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded

NCI selects UChicago Medicine as a lead site for clinical trials

As FDA’s wheels almost entirely come off, NCI remains sturdy—a cancer moonshot may even be on the horizon

Renew today!

Subscriber content

Never miss an issue!

Login

Richard Fisher steps down from leadership roles at Fox Chase Cancer Center

YOU MAY BE INTERESTED IN

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas“Institutions are feeling crunched in so many different directions”

NCI renews the UC San Diego Moores CCSG, committing $25M

House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget

As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick labThe job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded

NCI selects UChicago Medicine as a lead site for clinical trials

As FDA’s wheels almost entirely come off, NCI remains sturdy—a cancer moonshot may even be on the horizon

Never miss an issue!

Login

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions”

As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded